News | May 23, 2023
Devyser and QIAGEN collaborate on pre-analytical workflow for fetal RHD screening
Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma samples. Due to the very low concentrations of cfDNA found in plasma, robust pre-analytical methods are...
Find out more